Local Neurotoxicity and Myotoxicity Evaluation of Cyclodextrin Complexes of Bupivacaine and Ropivacaine

• DOI: 10.1213/ane.0b013e318266f3d9
• Publication Date: 2012-07-20T19:12:52Z
• Authors: Cintia Maria Saia...; Giovana Radomille...; Luiz Gabriel Matu...; Amauri Pierucci; Lazaro Alessandro...; Michelle Franz-Mo...; Alexandre Leite R...; Sarah Arana; Daniele Ribeiro d...; Eneida de Paula
• Keywords: Male; Cyclodextrins; Drug Evaluation, Preclinical; Amides; Bupivacaine; Sciatic Nerve; Rats; 3. Good health; 03 medical and health sciences; 0302 clinical medicine; Animals, Newborn; Muscular Diseases; Animals; Ropivacaine; Rats, Wistar; Cells, Cultured

Bupivacaine (BVC) and ropivacaine (RVC) are local anesthetics widely used in surgical procedures. In previous studies, inclusion complexes of BVC or RVC in hydroxypropyl-β-cyclodextrin (HP-β-CD) increased differential nervous blockade, compared to the plain anesthetic solutions. In this study we evaluated the local neural and muscular toxicity of these new formulations containing 0.5% BVC or RVC complexed with HP-β-CD (BVC(HP-β-CD) and RVC(HP-β-CD)).Schwann cell viability was assessed by determination of mitochondrial dehydrogenase activity, and histopathological evaluation of the rat sciatic nerve was used to identify local neurotoxic effects (48 hours and 7 days after the treatments). Evaluations of serum creatine kinase levels and the histopathology of rat gastrocnemius muscle (48 hours after treatment) were also performed.Schwann cell toxicity evaluations revealed no significant differences between complexed and plain local anesthetic formulations. However, use of the complexed local anesthetics reduced serum creatine kinase levels 5.5-fold, relative to the plain formulations. The differences were significant at P < 0.05 (BVC) and P < 0.01 (RVC). The histopathological muscle evaluation showed that differences between groups treated with local anesthetics (BVC or RVC) and their respective complexed formulations (BVC(HP-β-CD) or RVC(HP-β-CD)) were significant (P < 0.05).We concluded that the new formulations presented a lower myotoxicity and a similar cytotoxic effect when compared to plain local anesthetic solutions.